Pharmageddon,' a documentary directed by Donal O'Neill and produced by cardiologist Aseem Malhotra, was launched recently at ...

Throughout the last three months, 12 analysts have evaluated Rhythm Pharmaceuticals RYTM, offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of ...

Regeneron Pharmaceuticals is acquiring 23andMe for $256 million. Regeneron is going to keep the consumer genetics business. A big opportunity lies in using much of that data for research purposes.

Kennedy Jr., Dr. Fiona Godlee, Jay Bhattacharya MD and Dr. Vandana Shiva. It delves into the pharmaceutical industry and the rise of diet-related diseases. “We have a pandemic of misinformed ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to ...

The pharmaceutical construction industry has seen explosive growth, a trend with substantial implications for healthcare industry, and global health outcomes. The COVID-19 pandemic underscored the ...

More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of care treatment, and one-quarter are left untreatedLTC residents are ...

Ellie Stathaki is the Architecture & Environment Director at Wallpaper*. She trained as an architect at the Aristotle University of Thessaloniki in Greece and studied architectural history at the ...

PASADENA, Calif., June 02, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-ALK7, the company’s ...

The logo of Sanofi is seen at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File Photo France's Sanofi ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...